Wednesday, December 31, 2008

FDA Panel to Weigh Fate of Heart Drug Prasugrel in February

Approval of Lilly's anti-clotting drug prasugrel has been delayed twice this year. Now a February date has been set for a panel meeting to mull the medicine in public.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)